We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SMBK:NYSESmartFinancial, Inc. Analysis

Data as of 2026-06-30 - not real-time

$47.14

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

SmartFinancial, Inc. is trading at $47.14, well below its discounted cash‑flow fair value of $63.32, indicating a sizable valuation gap. The stock sits comfortably above its 20‑day (44.21) and 50‑day (42.66) moving averages, with the 200‑day SMA (39.15) also trending upward, and the MACD histogram remains positive, signaling a bullish technical backdrop. However, the RSI of 69.6 approaches overbought territory, suggesting a potential short‑term pullback as price nears the recent resistance of $47.97. Fundamentally, the company delivers strong profitability – operating margin of 37.8% and profit margin of 26.9% – while revenue grew 8.3% year‑over‑year. Its forward PE of 11.2 contrasts favorably with the industry average of 16.9, and a low debt load ($124.8 M) plus $357.6 M in cash underscore a solid balance sheet. The dividend yield of 0.7% with a modest 10% payout ratio appears sustainable. Risk metrics show a relatively low beta of 0.61 and increasing volume, though 30‑day volatility is elevated at 23.5%. Overall, the combination of undervaluation, robust earnings, and strong cash position supports a bullish outlook.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish technical alignment with SMA and MACD
  • Price below DCF fair value providing upside
  • Increasing volume supporting momentum

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong operating margins and earnings growth
  • Forward PE advantage versus industry peers
  • Low leverage and ample cash reserves

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Sustainable dividend with low payout ratio
  • Stable regional footprint with limited geographic risk
  • Undervalued valuation metrics and continued earnings expansion

Key Metrics & Analysis

Financial Health

Revenue Growth8.30%
Profit Margin26.85%
P/E Ratio15.1
ROE9.88%
ROA0.93%
P/B Ratio1.4
Op. Cash Flow$63.8M
Industry P/E16.9

Technical Analysis

TrendBullish
RSI69.6
Support$40.35
Resistance$47.97
MA 20$44.21
MA 50$42.66
MA 200$39.15
MACDBullish
VolumeIncreasing
Fear & Greed Index89.91

Valuation

Fair Value$63.32
Target Price$47.46
Upside/Downside0.68%
GradeUndervalued
TypeBlend
Dividend Yield0.70%

Risk Assessment

Beta0.61
Volatility23.49%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.